| scholarly article | Q13442814 |
| P50 | author | Norman Sharpless | Q21260355 |
| Matthew R. Ramsey | Q55130884 | ||
| P2093 | author name string | Yue Xiong | |
| Keith L Ligon | |||
| Chad Torrice | |||
| Janakiraman Krishnamurthy | |||
| Weili Lin | |||
| Daniel R Carrasco | |||
| Xin-Hai Pei | |||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4732-4741 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues | |
| P478 | volume | 67 |
| Q30824986 | An essential role for Ink4 and Cip/Kip cell-cycle inhibitors in preventing replicative stress |
| Q38352238 | BMI1 sustains human glioblastoma multiforme stem cell renewal |
| Q37235490 | CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis |
| Q37575488 | CDK4/6 inhibition induces epithelial cell cycle arrest and ameliorates acute kidney injury. |
| Q111442280 | CDK4/6 inhibitors induce replication stress to cause long‐term cell cycle withdrawal |
| Q58789954 | Cell Cycle Regulators and Lineage-Specific Therapeutic Targets for Cushing Disease |
| Q38123666 | Cell cycle regulation by long non-coding RNAs |
| Q37419484 | Cellular senescence: its role in tumor suppression and aging |
| Q37313723 | Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme |
| Q38733868 | Effect of reversine on cell cycle, apoptosis, and activation of hepatic stellate cells |
| Q39836171 | Enhanced Megakaryopoiesis and Platelet Activity in Hypercholesterolemic, B6-Ldlr-/-, Cdkn2a-Deficient Mice |
| Q34754281 | Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes |
| Q24317761 | Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development |
| Q35766946 | Free fatty acids block glucose-induced β-cell proliferation in mice by inducing cell cycle inhibitors p16 and p18 |
| Q33984418 | Genetically engineered mouse models of pituitary tumors |
| Q42509342 | Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation. |
| Q30251397 | Islet biology, the CDKN2A/B locus and type 2 diabetes risk |
| Q37628691 | Key signaling molecules in pituitary tumors |
| Q33647719 | Metastasis in an orthotopic murine model of melanoma is independent of RAS/RAF mutation |
| Q33968055 | Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition. |
| Q35842970 | Multiple roles of cyclin-dependent kinase 4/6 inhibitors in cancer therapy |
| Q37597258 | NFIB-mediated repression of the epigenetic factor Ezh2 regulates cortical development |
| Q37293878 | Oval cell proliferation in p16INK4a expressing mouse liver is triggered by chronic growth stimuli. |
| Q38832541 | Preclinical development of G1T38: A novel, potent and selective inhibitor of cyclin dependent kinases 4/6 for use as an oral antineoplastic in patients with CDK4/6 sensitive tumors |
| Q37309123 | Real-time in vivo imaging of p16Ink4a reveals cross talk with p53. |
| Q42917409 | Real-time in vivo imaging of p16gene expression: a new approach to study senescence stress signaling in living animals |
| Q37880852 | Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer |
| Q38728895 | Repression of CDKN2C caused by PML/RARα binding promotes the proliferation and differentiation block in acute promyelocytic leukemia |
| Q34429099 | Somatic p16(INK4a) loss accelerates melanomagenesis |
| Q37070705 | Systematic verification of upstream regulators of a computable cellular proliferation network model on non-diseased lung cells using a dedicated dataset |
| Q33728087 | The negative cell cycle regulators, p27(Kip1), p18(Ink4c), and GSK-3, play critical role in maintaining quiescence of adult human pancreatic β-cells and restrict their ability to proliferate |
| Q36291101 | Transcriptional repression of CDKN2D by PML/RARα contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells |
| Q90423071 | Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial |
| Q41828430 | p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor |
| Q33743648 | p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation |
Search more.